簡易檢索 / 詳目顯示

研究生: 張宏州
Chang, Hung-Chou
論文名稱: 天然OTM66對氣喘反應之研究
STUDY OF FORMULATION ON ASTHMATIC RESPONSES
指導教授: 麥愛堂教授
Oi-Tong Mak
曾淑芬教授
Tzeng, Shun-Fen
學位類別: 博士
Doctor
系所名稱: 生物科學與科技學院 - 生命科學系
Department of Life Sciences
論文出版年: 2014
畢業學年度: 102
語文別: 英文
論文頁數: 85
中文關鍵詞: 氣喘草藥天竺鼠肥大細胞發炎細胞組織胺細胞激素支氣管擴張劑腎上腺素神經傳導路徑
外文關鍵詞: asthma, herb, guinea pig, mast cell, inflammatory cell, histamine, cytokine, bronchodilator, adrenergic pathway
相關次數: 點閱:91下載:1
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 幾世紀以來在亞洲國家裡許多經證實具有對氣喘具有療效的傳統中草藥,包括單方及複方等,都是經以口服的方式來進行治療。在本實驗以卵蛋白素(ovalbumin)作為過敏原刺激已致敏化的天竺鼠,再施予氣霧化複方中草藥(CTCM)。我們所使用的複方中草藥命名為OTM66,此配方在經過煎煮後以霧化的方式讓實驗動物吸入。實驗結果顯示OTM66可以有效的抑制由OVA引發致敏化天竺鼠的氣喘反應包括呼吸道阻力、介白素-5 (IL-5)的濃度以及發炎細胞數量等的增加,並且發現OTM66也具有支氣管擴張劑的效用,另外β-腎上腺素受體的拮抗劑propranolol會減弱由OTM66對於已致敏化呼吸道阻力的抑制作用。此外本實驗還利用肥大細胞株P815作體外細胞實驗,以compound 48/80刺激P815引發細胞去顆粒化 (degranulation) 並釋放出組織胺以及介白素-4 (IL-4)等物質,經實驗結果發現經OTM66可以抑制P815所釋放的組織胺和介白素-4,透過顯微鏡觀察發現產生去顆粒化的P815也有明顯的減少。由此證實OTM66可以有效抑制氣喘的反應,包括立即性的支氣管收縮以及延遲性的發炎細胞增生等,而且此複方中藥之作用機制包括可以透過刺激β-交感神經受器來擴張支氣管,也可以透過穩定肥大細胞避免其去顆粒化的現象來抑制氣喘反應。

    Since traditional Chinese medicines can effectively relieve symptoms of asthma, the agents have been used as oral medications for anti-asthma in Asian countries within centuries. In this study, we showed a novel medication by developing of a complex traditional Chinese medicine (CTCM) in nebulized form, so called as OTM66. OTM66 was applied through the intratracheal route and found to be effective against an early-phase air-flow obstruction in ovalbumin (OVA)-sensitized guinea pigs. The application of OTM66 inhibited IL-5 production in OVA-sensitized guinea pigs. We further examined the mechanism of OTM66 to determine its function in the early-phase response to OVA challenge. Using we found that the inhibition of bronchoconstriction by OTM66 was attenuated by pretreatment with the β-adrenergic antagonist propranolol, suggesting that OTM66 exerts a bronchodilator effect via the β-adrenergic receptor-dependent pathway. Moreover, OTM66 was able to inhibit histamine and IL-4 secretion in the OVA-induced airway hypersensitivity in guinea pigs at 5 min post-OVA challenge. The in vitro study using P815 revealed that treatment with OTM66 stabilized mast cells. In conclusion, our results indicate that OTM66 is a promising bronchodilator and works well as a mast cell stabilizer. The findings provide important evidence showing its application for the treatment of allergenic airway disorders.

    Table of Contents 中文摘要.............................................................................................................................I ABSTRACT.......................................................................................................................II ACKNOWLEDGEMENTS.……………………………………………………………IV ABBREVIATIONS………………………………………………………………………X Chapter 1 Introduction…………………………………………………………………1 1.1. Definition...................................................................................................................2 1.2. Classification and Mechanism of Asthma…………………………………………..2 1.2.1. Extrinsic Asthma ………………………………………………………………………..3 1.2.2. Intrinsic Asthma…………………………………………………………………………4 1.3. Airway Neural Mechanisms in Asthma……………………………………………..5 1.3.1. Cholinergic Pathway……………………………………………………………………5 1.3.2. Adrenergic Pathway…………………………………………………………………….6 1.3.3. NANC Pathway………………………………………………………………………….6 1.4. Major cells in Asthma……………………………………………………………….7 1.4.1. Mast Cells……………………………………………………………………...………...7 1.4.2. Eosinophils………………………………………………………………………….…...9 1.4.3. Lymphocytes……………………………………………………………………………..9 1.4.4. Others………………………………………............................................................10 1.5. Asthma Related Inflammatory Mediators…………………………………………10 1.5.1. Prostaglandins (PGs) and Leukotrienes (LTs)…………………………………….10 1.5.1.1. cyclooxygenase pathway…………………………………………………10 1.5.1.2. liopoxygenase pathway…………………………………………………...10 1.5.1.3. cytochrome P-450 epoxygenase pathway………………………………...10 1.5.2. Interleukins (ILs)………………………………………………………………………11 1.6. Current Asthma Medicines……………………………………………………………12 1.6.1. Anti-inflammatory……………………………………………………………………..12 1.6.1.1. Steroids (e.g., beclomethasone budesonide and fluticasone)……………..12 1.6.1.2. Cromolyn sodium…………………………………………………………13 1.6.1.3. Antileukotrienes (e.g., zafirlukast and montelukast)…………………..…13 1.6.2. Bronchodilators……………………………………………………………………..…13 1.6.2.1. β2-agonists (e.g., salbutamol, salmeterol and formoterol)……………..…13 1.6.2.2. Theophylline derivatives (e.g., aminophylline and theophylline)………...14 1.6.2.3. Anticholinergics (e.g., ipratropium)……………………………………....14 1.7. Records and Treatments in Traditional Chinese Medicine………………………...15 Chapter 2 Aims of study……………………………………………………………….18 Chapter 3 Materials and Methods…………………………………………………….21 3.1. Materials……………………………………………………………………………22 3.1.1. Experimental animals…………………………………………………………………22 3.1.2. Chemicals………………………………………………………………………………22 3.1.3. Experimental Instruments…………………………………………………………....23 3.2. Methods……………………………………………………………………………23 3.2.1. Sensitization and challenge of animals……………………………………………..23 3.2.2. Preparation of the Chinese herbal formula(OTM66)……………………….……24 3.2.3. The airway hyperresponsiveness (AHR) of methacholine (Mch)……………….25 3.2.4. Experimental design and administration…………………………………………..26 3.2.5. Measurement of airway responses to OVA challenge……………………………27 3.2.6. IgE in serum……………………………………………………………………………27 3.2.7. Bronchoalveolar lavage………………………………………………………………28 3.2.8. IL-5 in bronchoalveolar lavage fluid (BALF)……………………………………..28 3.2.9. Histamine and IL-4 in bronchoalveolar lavage fluid (BALF)…………………..28 3.2.10. Effects of the OTM66 on the inhibition of histamine and IL-4 release in a mast cell culture…………………………………………………29 3.2.11. Statistical analysis…………………………………………………………………..30 Chapter 4 Results………………………………………………………………………31 4.1. Effects of Mch on the airway………………………………………………………32 4.2. IgE in the serum of unsensitized and OVA-sensitized guinea pigs after challenge………………………………………………………...32 4.3. RL of guinea pigs after challenge…………………………………………………...32 4.4. Effect of OTM66 on allergen-induced respiratory resistance……………………...33 4.5. Effect of OTM66 on OVA-induced inflammatory cells infiltration in BALF………………………………………………………….33 4.6. IL-5 in the BALF of the guinea pigs……………………………………………….34 4.7. The OTM66 has a bronchodilating effect………………………………………….34 4.8. The bronchodilating effect of the OTM66 is associated with the β-adrenoceptor…34 4.9. The OTM66 reduced the histamine and IL-4 levels in the BALF of OVA-challenged guinea pigs……………………………………………35 4.10.The OTM66 reduced histamine and IL-4 release in activated P815 cells…………36 Chapter 5 Discussion…………………………………………………………………...38 Chapter 6 Conclusions…………………………………………………………………48 REFERENCES……………………………………………………………………….…..50 FIGURES…………………………………………………………………………………68 APPENDIXES……………………………………………………………………………82 CURRICULUM VITAE…………………………………………………………………85

    Reference

    Abraham WM, Bourdelais AJ, Sabater JR, Ahmed A, Lee TA, Serebriakov I, Baden DG (2005) Airway responses to aerosolized brevetoxins in an animal model of asthma. American journal of respiratory and critical care medicine 171:26-34.
    Abraham WM, Burch RM, Farmer SG, Sielczak MW, Ahmed A, Cortes A (1991) A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep. The American review of respiratory disease 143:787-796.
    Armour CL, Hughes JM, Seale JP, Temple DM (1982) Effects of sodium cromoglycate analogues on the immunological release of slow reacting substance of anaphylaxis and histamine from human and guinea-pig lung in vitro. The Journal of pharmacy and pharmacology 34:401-402.
    Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD (1999) A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. American journal of respiratory cell and molecular biology 20:976-983.
    Banasiak NC, Meadows-Oliver M (2005) Leukotrienes: their role in the treatment of asthma and seasonal allergic rhinitis. Pediatric nursing 31:35-38.
    Barnes PJ (1986) Neural control of human airways in health and disease. The American review of respiratory disease 134:1289-1314.
    Barnes PJ (1991) Neuropeptides and asthma. The American review of respiratory disease 143:S28-32.
    Barnes PJ (1993a) Muscarinic receptor subtypes in airways. Life sciences 52:521-527.
    Barnes PJ (1993b) Muscarinic receptor subtypes in airways. The European respiratory journal 6:328-331.
    Barnes PJ (2010) New therapies for asthma: is there any progress? Trends in pharmacological sciences 31:335-343.
    Barnes PJ, Basbaum CB, Nadel JA (1983a) Autoradiographic localization of autonomic receptors in airway smooth muscle. Marked differences between large and small airways. The American review of respiratory disease 127:758-762.
    Barnes PJ, Minette P, Maclagan J (1988) Muscarinic receptor subtypes in airways. Trends in pharmacological sciences 9:412-416.
    Barnes PJ, Skoogh BE, Brown JK, Nadel JA (1983b) Activation of alpha-adrenergic response in tracheal smooth muscle: a postreceptor mechanism. Journal of applied physiology: respiratory, environmental and exercise physiology 54:1469-1476.
    Basbaum CB, Barnes PJ, Grillo MA, Widdicombe JH, Nadel JA (1983) Adrenergic and cholinergic receptors in submucosal glands of the ferret trachea: autoradiographic localization. European journal of respiratory diseases Supplement 128 (Pt 2):433-435.
    Beasley R, Roche WR, Roberts JA, Holgate ST (1989) Cellular events in the bronchi in mild asthma and after bronchial provocation. The American review of respiratory disease 139:806-817.
    Beasley R, Varley J, Robinson C, Holgate ST (1987) Cholinergic-mediated bronchoconstriction induced by prostaglandin D2, its initial metabolite 9 alpha,11 beta-PGF2, and PGF2 alpha in asthma. The American review of respiratory disease 136:1140-1144.
    Bel EH, Timmers MC, Hermans J, Dijkman JH, Sterk PJ (1990) The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. The American review of respiratory disease 141:21-28.
    Belvisi MG, Stretton CD, Miura M, Verleden GM, Tadjkarimi S, Yacoub MH, Barnes PJ (1992a) Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter. Journal of applied physiology 73:2505-2510.
    Belvisi MG, Stretton CD, Yacoub M, Barnes PJ (1992b) Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. European journal of pharmacology 210:221-222.
    Bhagat RG, Grunstein MM (1984) Comparison of responsiveness to methacholine, histamine, and exercise in subgroups of asthmatic children. The American review of respiratory disease 129:221-224.
    Biggs DF (1998) Neuropeptides: do they have a role in the pathogenesis of asthma? Canadian respiratory journal : journal of the Canadian Thoracic Society 5:33-34.
    Booij-Noord H, Orie NG, De Vries K (1971) Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. The Journal of allergy and clinical immunology 48:344-354.
    Bradding P (1999) Allergen immunotherapy and mast cells. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 29:1445-1448.
    Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JP, Hunt TC, Okayama Y, Heusser CH, et al. (1992) Interleukin 4 is localized to and released by human mast cells. The Journal of experimental medicine 176:1381-1386.
    Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, Howarth PH (1993) Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. Journal of immunology 151:3853-3865.
    Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST (1994) Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. American journal of respiratory cell and molecular biology 10:471-480.
    Brown MA, Halonen M (1999) Perinatal events in the development of asthma. Current opinion in pulmonary medicine 5:4-9.
    Burns AJ, Thapar N, Barlow AJ (2008) Development of the neural crest-derived intrinsic innervation of the human lung. American journal of respiratory cell and molecular biology 38:269-275.
    Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG (1989) Association of asthma with serum IgE levels and skin-test reactivity to allergens. The New England journal of medicine 320:271-277.
    Busse PJ, Schofield B, Birmingham N, Yang N, Wen MC, Zhang T, Srivastava K, Li XM (2010) The traditional Chinese herbal formula ASHMI inhibits allergic lung inflammation in antigen-sensitized and antigen-challenged aged mice. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 104:236-246.
    Busse W, Kraft M (2005) Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest 127:1312-1326.
    Busse WW (1996) The role of leukotrienes in asthma and allergic rhinitis. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 26:868-879.
    Busse WW, Lemanske RF, Jr. (2001) Asthma. The New England journal of medicine 344:350-362.
    Butchers PR, Skidmore IF, Vardey CJ, Wheeldon A (1980) Characterization of the receptor mediating the antianaphylactic effects of beta-adrenoceptor agonists in human lung tissue in vitro. British journal of pharmacology 71:663-667.
    Calhoun WJ (1998) Summary of clinical trials with zafirlukast. American journal of respiratory and critical care medicine 157:S238-245; discussion S245-238.
    Calhoun WJ, Lavins BJ, Minkwitz MC, Evans R, Gleich GJ, Cohn J (1998) Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge. American journal of respiratory and critical care medicine 157:1381-1389.
    Careau E, Sirois J, Bissonnette EY (2002) Characterization of lung hyperresponsiveness, inflammation, and alveolar macrophage mediator production in allergy resistant and susceptible rats. American journal of respiratory cell and molecular biology 26:579-586.
    Casale TB (1987) Neuromechanisms of asthma. Annals of allergy 59:391-398.
    Casale TB, Marom Z (1983) Mast cells and asthma. The role of mast cell mediators in the pathogenesis of allergic asthma. Annals of allergy 51:2-6.
    Castle W, Fuller R, Hall J, Palmer J (1993) Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. Bmj 306:1034-1037.
    Chan CK, Kuo ML, Shen JJ, See LC, Chang HH, Huang JL (2006) Ding Chuan Tang, a Chinese herb decoction, could improve airway hyper-responsiveness in stabilized asthmatic children: a randomized, double-blind clinical trial. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 17:316-322.
    Chang HC, Gong CC, Chen JL, Mak OT (2011) Inhibitory effects of inhaled complex traditional Chinese medicine on early and late asthmatic responses induced by ovalbumin in sensitized guinea pigs. BMC complementary and alternative medicine 11:80.
    Chatham M, Bleecker ER, Smith PL, Rosenthal RR, Mason P, Norman PS (1982) A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects. The American review of respiratory disease 126:235-240.
    Choi DC, Kwon OJ (1998) Neuropeptides and asthma. Current opinion in pulmonary medicine 4:16-24.
    Chung KF, Barnes PJ (1999) Cytokines in asthma. Thorax 54:825-857.
    Church MK, Okayama Y, Bradding P (1994) The role of the mast cell in acute and chronic allergic inflammation. Annals of the New York Academy of Sciences 725:13-21.
    Ciprandi G, Marseglia GL, Tosca MA (2006) Allergen-specific immunotherapy: an update on immunological mechanisms of action. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Universita di Napoli, Secondo ateneo 65:34-37.
    Cockcroft DW, Murdock KY (1987) Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. The Journal of allergy and clinical immunology 79:734-740.
    Curzen N, Rafferty P, Holgate ST (1987) Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man. Thorax 42:946-952.
    De Monchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, De Vries K (1985) Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. The American review of respiratory disease 131:373-376.
    Diaz P, Gonzalez MC, Galleguillos FR, Ancic P, Cromwell O, Shepherd D, Durham SR, Gleich GJ, Kay AB (1989) Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. The American review of respiratory disease 139:1383-1389.
    Donnelly LE, Tudhope SJ, Fenwick PS, Barnes PJ (2010) Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages. The European respiratory journal 36:178-186.
    Drew CD, Knight GT, Hughes DT, Bush M (1978) Comparison of the effects of D-(-)-ephedrine and L-(+)-pseudoephedrine on the cardiovascular and respiratory systems in man. British journal of clinical pharmacology 6:221-225.
    Fahy JV, Kim KW, Liu J, Boushey HA (1995) Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. The Journal of allergy and clinical immunology 95:843-852.
    Faurschou P, Bing J, Edman G, Engel AM (1994a) Comparison between sodium cromoglycate (MDI: metered-dose inhaler) and beclomethasone dipropionate (MDI) in treatment of adult patients with mild to moderate bronchial asthma. A double-blind, double-dummy randomized, parallel-group study. Allergy 49:659-663.
    Faurschou P, Engel AM, Haanaes OC (1994b) Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies. Allergy 49:827-832.
    Fedan JS, Frazer DG (1992) Influence of epithelium on the reactivity of guinea pig isolated, perfused trachea to bronchoactive drugs. The Journal of pharmacology and experimental therapeutics 262:741-750.
    Fireman P (2003) Understanding asthma pathophysiology. Allergy and asthma proceedings : the official journal of regional and state allergy societies 24:79-83.
    Foster PS, Hogan SP, Yang M, Mattes J, Young IG, Matthaei KI, Kumar RK, Mahalingam S, Webb DC (2002) Interleukin-5 and eosinophils as therapeutic targets for asthma. Trends in molecular medicine 8:162-167.
    Fox B, Bull TB, Guz A (1980) Innervation of alveolar walls in the human lung: an electron microscopic study. Journal of anatomy 131:683-692.
    Gleich GJ (2000) Mechanisms of eosinophil-associated inflammation. The Journal of allergy and clinical immunology 105:651-663.
    Haddad EB, Landry Y, Gies JP (1991) Muscarinic receptor subtypes in guinea pig airways. The American journal of physiology 261:L327-333.
    Haley KJ, Sunday ME, Wiggs BR, Kozakewich HP, Reilly JJ, Mentzer SJ, Sugarbaker DJ, Doerschuk CM, Drazen JM (1998) Inflammatory cell distribution within and along asthmatic airways. American journal of respiratory and critical care medicine 158:565-572.
    Halonen M, Stern DA, Lohman C, Wright AL, Brown MA, Martinez FD (1999) Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk. American journal of respiratory and critical care medicine 160:564-570.
    Hargreave FE (1989) Late-phase asthmatic responses and airway inflammation. The Journal of allergy and clinical immunology 83:525-527.
    Hashimoto K, Yanagisawa T, Okui Y, Ikeya Y, Maruno M, Fujita T (1994) Studies on anti-allergic components in the roots of Asiasarum sieboldi. Planta medica 60:124-127.
    Hegardt B, Pauwels R, Van Der Straeten M (1981) Inhibitory effect of KWD 2131, terbutaline, and DSCG on the immediate and late allergen-induced bronchoconstriction. Allergy 36:115-122.
    Holgate ST, Kay AB (1985) Mast cells, mediators and asthma. Clinical allergy 15:221-234.
    Howarth PH, Bradding P, Quint D, Redington AE, Holgate ST (1994) Cytokines and airway inflammation. Annals of the New York Academy of Sciences 725:69-82.
    Hutson PA, Church MK, Clay TP, Miller P, Holgate ST (1988a) Early and late-phase bronchoconstriction after allergen challenge of nonanesthetized guinea pigs. I. The association of disordered airway physiology to leukocyte infiltration. The American review of respiratory disease 137:548-557.
    Hutson PA, Holgate ST, Church MK (1988b) The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs. The American review of respiratory disease 138:1157-1163.
    Iijima H, Ishii M, Yamauchi K, Chao CL, Kimura K, Shimura S, Shindoh Y, Inoue H, Mue S, Takishima T (1987) Bronchoalveolar lavage and histologic characterization of late asthmatic response in guinea pigs. The American review of respiratory disease 136:922-929.
    Inman MD, Ellis R, Wattie J, Denburg JA, O'Byrne PM (1999) Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. American journal of respiratory cell and molecular biology 21:473-479.
    Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ (1999) Neutrophilic inflammation in severe persistent asthma. American journal of respiratory and critical care medicine 160:1532-1539.
    Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet LP, Haukioja A (1995) Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. American journal of respiratory and critical care medicine 151:66-70.
    Kao ST, Chang CH, Chen YS, Chiang SY, Lin JG (2004) Effects of Ding-Chuan-Tang on bronchoconstriction and airway leucocyte infiltration in sensitized guinea pigs. Immunopharmacology and immunotoxicology 26:113-124.
    Kao ST, Lin CS, Hsieh CC, Hsieh WT, Lin JG (2001a) Effects of xiao-qing-long-tang (XQLT) on bronchoconstriction and airway eosinophil infiltration in ovalbumin-sensitized guinea pigs: in vivo and in vitro studies. Allergy 56:1164-1171.
    Kao ST, Wang SD, Wang JY, Yu CK, Lei HY (2000a) The effect of Chinese herbal medicine, xiao-qing-long tang (XQLT), on allergen-induced bronchial inflammation in mite-sensitized mice. Allergy 55:1127-1133.
    Kao ST, Yeh TJ, Hsieh CC, Shiau HB, Yeh FT, Lin JG (2001b) The effects of Ma-Xing-Gan-Shi-Tang on respiratory resistance and airway leukocyte infiltration in asthmatic guinea pigs. Immunopharmacology and immunotoxicology 23:445-458.
    Kao ST, Yeh TJ, Hsieh CC, Yeh FT, Lin JG (2000b) Effect of San-Ao-Tang on immediate and late airway response and leukocyte infiltration in asthmatic guinea pigs. Immunopharmacology and immunotoxicology 22:143-162.
    Kay AB (1983) Mast cells and their mediators in the pathogenesis of asthma. European journal of respiratory diseases Supplement 128 (Pt 1):50-52.
    Kikuchi S, Nagata M, Kikuchi I, Hagiwara K, Kanazawa M (2005) Association between neutrophilic and eosinophilic inflammation in patients with severe persistent asthma. International archives of allergy and immunology 137 Suppl 1:7-11.
    Kim SJ, Gao Zhang C, Taek Lim J (2003) Mechanism of anti-nociceptive effects of Asarum sieboldii Miq. radix: potential role of bradykinin, histamine and opioid receptor-mediated pathways. Journal of ethnopharmacology 88:5-9.
    Kirshenbaum A (2000) Regulation of mast cell number and function. Hematology/oncology clinics of North America 14:497-516, v.
    Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD (1999) Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 94:2333-2342.
    Kita H, Jorgensen RK, Reed CE, Dunnette SL, Swanson MC, Bartemes KR, Squillace D, Blomgren J, Bachman K, Gleich GJ (2000) Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected. The Journal of allergy and clinical immunology 106:521-529.
    Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ (1996) Alveolar tissue inflammation in asthma. American journal of respiratory and critical care medicine 154:1505-1510.
    Kraneveld AD, James DE, de Vries A, Nijkamp FP (2000) Excitatory non-adrenergic-non-cholinergic neuropeptides: key players in asthma. European journal of pharmacology 405:113-129.
    Lantz CS, Yamaguchi M, Oettgen HC, Katona IM, Miyajima I, Kinet JP, Galli SJ (1997) IgE regulates mouse basophil Fc epsilon RI expression in vivo. Journal of immunology 158:2517-2521.
    Larbi KY, Allen AR, Tam FW, Haskard DO, Lobb RR, Silva PM, Nourshargh S (2000) VCAM-1 has a tissue-specific role in mediating interleukin-4-induced eosinophil accumulation in rat models: evidence for a dissociation between endothelial-cell VCAM-1 expression and a functional role in eosinophil migration. Blood 96:3601-3609.
    Lee T, Lenihan DJ, Malone B, Roddy LL, Wasserman SI (1984) Increased biosynthesis of platelet-activating factor in activated human eosinophils. The Journal of biological chemistry 259:5526-5530.
    Leigh R, Ellis R, Wattie J, Southam DS, De Hoogh M, Gauldie J, O'Byrne PM, Inman MD (2002) Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. American journal of respiratory cell and molecular biology 27:526-535.
    Leigh R, Ellis R, Wattie JN, Hirota JA, Matthaei KI, Foster PS, O'Byrne PM, Inman MD (2004) Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. American journal of respiratory and critical care medicine 169:860-867.
    Lewis CA, Broadley KJ (1995) Airway hyper- or hyporeactivity to inhaled spasmogens 24 h after ovalbumin challenge of sensitized guinea-pigs. British journal of pharmacology 116:2351-2358.
    Li GZ, Chai OH, Lee MS, Han EH, Kim HT, Song CH (2005) Inhibitory effects of Houttuynia cordata water extracts on anaphylactic reaction and mast cell activation. Biological & pharmaceutical bulletin 28:1864-1868.
    Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, Lo D (1999) Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. Journal of immunology 162:2477-2487.
    Li XM, Wang QF, Schofield B, Lin J, Huang SK, Wang Q (2009) Modulation of antigen-induced anaphylaxis in mice by a traditional chinese medicine formula, Guo Min Kang. The American journal of Chinese medicine 37:113-125.
    Li Y, Martin LD, Minnicozzi M, Greenfeder S, Fine J, Pettersen CA, Chorley B, Adler KB (2001) Enhanced expression of mucin genes in a guinea pig model of allergic asthma. American journal of respiratory cell and molecular biology 25:644-651.
    Liu MC, Dube LM, Lancaster J (1996) Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group. The Journal of allergy and clinical immunology 98:859-871.
    Macdowell AL, Peters SP (2007) Neutrophils in asthma. Current allergy and asthma reports 7:464-468.
    Mariotto S, Esposito E, Di Paola R, Ciampa A, Mazzon E, de Prati AC, Darra E, Vincenzi S, Cucinotta G, Caminiti R, Suzuki H, Cuzzocrea S (2008) Protective effect of Arbutus unedo aqueous extract in carrageenan-induced lung inflammation in mice. Pharmacological research : the official journal of the Italian Pharmacological Society 57:110-124.
    Martin JG, Suzuki M, Maghni K, Pantano R, Ramos-Barbon D, Ihaku D, Nantel F, Denis D, Hamid Q, Powell WS (2002) The immunomodulatory actions of prostaglandin E2 on allergic airway responses in the rat. Journal of immunology 169:3963-3969.
    Matsumoto T, Ashida Y, Tsukuda R (1994) Pharmacological modulation of immediate and late airway response and leukocyte infiltration in the guinea pig. The Journal of pharmacology and experimental therapeutics 269:1236-1244.
    Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, Simson L, Hogan SP, Koskinen A, McKenzie AN, Dent LA, Rothenberg ME, Matthaei KI, Young IG, Foster PS (2002) Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. The Journal of experimental medicine 195:1433-1444.
    McLelland J, Abdalla AB (1972) The gross anatomy of the nerve supply to the lungs of Gallus domesticus. Anatomischer Anzeiger 131:448-453.
    Metzger WJ, Richerson HB, Worden K, Monick M, Hunninghake GW (1986) Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest 89:477-483.
    Minette PA, Barnes PJ (1988) Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways. Journal of applied physiology 64:2532-2537.
    Moiseeva EP, Bradding P (2011) Mast cells in lung inflammation. Advances in experimental medicine and biology 716:235-269.
    Naito A, Satoh H, Sekizawa K (2005) Asthma as well as anxiety improved by the Kampo extract Saiboku-to. European journal of internal medicine 16:621.
    Nathan RA, Bernstein JA, Bielory L, Bonuccelli CM, Calhoun WJ, Galant SP, Hanby LA, Kemp JP, Kylstra JW, Nayak AS, O'Connor JP, Schwartz HJ, Southern DL, Spector SL, Williams PV (1998) Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction. The Journal of allergy and clinical immunology 102:935-942.
    Orange RP, Austen WG, Austen KF (1971a) Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung : I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate. The Journal of experimental medicine 134:136-148.
    Orange RP, Kaliner MA, Laraia PJ, Austen KF (1971b) Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP. Federation proceedings 30:1725-1729.
    Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, Dockhorn RJ, Grossman J, Liddle RF, Yancey SW, et al. (1992) A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. The New England journal of medicine 327:1420-1425.
    Pelikan Z, Pelikan-Filipek M (1986) The late asthmatic response to allergen challenge--Part I. Annals of allergy 56:414-420.
    Pelikan Z, Pelikan M, Kruis M, Berger MP (1986) The immediate asthmatic response to allergen challenge. Annals of allergy 56:252-260.
    Perrin LF, Laurent PE (1993) Asthma and neuropeptides. The European journal of medicine 2:164-169.
    Pizzichini E, Leff JA, Reiss TF, Hendeles L, Boulet LP, Wei LX, Efthimiadis AE, Zhang J, Hargreave FE (1999) Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. The European respiratory journal 14:12-18.
    Quang TH, Ngan NT, Minh CV, Kiem PV, Tai BH, Thao NP, Song SB, Kim YH (2012) Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii. Bioorganic & medicinal chemistry letters 22:2527-2533.
    Rafferty P, Beasley R, Holgate ST (1987) The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma. The American review of respiratory disease 136:369-373.
    Redington AE, Bradding P, Holgate ST (1993) The role of cytokines in the pathogenesis of allergic asthma. Regional immunology 5:174-200.
    Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB (1998) Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Archives of internal medicine 158:1213-1220.
    Richardson JB (1979) Nerve supply to the lungs. The American review of respiratory disease 119:785-802.
    Roberts JA, Bradding P, Britten KM, Walls AF, Wilson S, Gratziou C, Holgate ST, Howarth PH (1999) The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. The European respiratory journal 14:275-282.
    Romagnani S (2004) Immunologic influences on allergy and the TH1/TH2 balance. The Journal of allergy and clinical immunology 113:395-400.
    Rottem M, Okada T, Goff JP, Metcalfe DD (1994) Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population. Blood 84:2489-2496.
    Saita E, Kishimoto Y, Tani M, Iizuka M, Toyozaki M, Sugihara N, Kondo K (2012) Antioxidant activities of Perilla frutescens against low-density lipoprotein oxidation in vitro and in human subjects. Journal of oleo science 61:113-120.
    Sanderson CJ (1992) Pharmacological implications of interleukin-5 in the control of eosinophilia. Advances in pharmacology 23:163-177.
    Sapienza S, Eidelman DH, Renzi PM, Martin JG (1990) Role of leukotriene D4 in the early and late pulmonary responses of rats to allergen challenge. The American review of respiratory disease 142:353-358.
    Scanlon RT (1984) Asthma: a panoramic view and a hypothesis. Annals of allergy 53:203-212.
    Sherrill DL, Stein R, Halonen M, Holberg CJ, Wright A, Martinez FD (1999) Total serum IgE and its association with asthma symptoms and allergic sensitization among children. The Journal of allergy and clinical immunology 104:28-36.
    Shi H, Qin S, Huang G, Chen Y, Xiao C, Xu H, Liang G, Xie Z, Qin X, Wu J, Li G, Zhang C (1997) Infiltration of eosinophils into the asthmatic airways caused by interleukin 5. American journal of respiratory cell and molecular biology 16:220-224.
    Shi HZ, Deng JM, Xu H, Nong ZX, Xiao CQ, Liu ZM, Qin SM, Jiang HX, Liu GN, Chen YQ (1998) Effect of inhaled interleukin-4 on airway hyperreactivity in asthmatics. American journal of respiratory and critical care medicine 157:1818-1821.
    Shibata H, Minami E, Hirata R, Mizutani N, Nabe T, Kohno S (2000) Immediate inhibition by oral l-ephedrine of passive cutaneous anaphylaxis of rats: indirect inhibition of anaphylactic chemical mediator release from the mast cell. Inflammation research : official journal of the European Histamine Research Society [et al] 49:553-559.
    Spina D, Rigby PJ, Paterson JW, Goldie RG (1989a) Alpha 1-adrenoceptor function and autoradiographic distribution in human asthmatic lung. British journal of pharmacology 97:701-708.
    Spina D, Rigby PJ, Paterson JW, Goldie RG (1989b) Autoradiographic localization of beta-adrenoceptors in asthmatic human lung. The American review of respiratory disease 140:1410-1415.
    Stretton D, Belvisi MG, Barnes PJ (1992) The effect of sensory nerve depletion on cholinergic neurotransmission in guinea pig airways. The Journal of pharmacology and experimental therapeutics 260:1073-1080.
    Svendsen UG, Frolund L, Madsen F, Nielsen NH (1989) A comparison of the effects of nedocromil sodium and beclomethasone dipropionate on pulmonary function, symptoms, and bronchial responsiveness in patients with asthma. The Journal of allergy and clinical immunology 84:224-231.
    Tai PC, Sun L, Spry CJ (1991) Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clinical and experimental immunology 85:312-316.
    Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O'Byrne PM, Lofdahl CG, Pauwels RA, Ullman A (1999) Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. American journal of respiratory and critical care medicine 160:594-599.
    Taylor DR, Town GI, Herbison GP, Boothman-Burrell D, Flannery EM, Hancox B, Harre E, Laubscher K, Linscott V, Ramsay CM, Richards G (1998) Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol. Thorax 53:744-752.
    Tedeschi E, Menegazzi M, Yao Y, Suzuki H, Forstermann U, Kleinert H (2004) Green tea inhibits human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha activation. Molecular pharmacology 65:111-120.
    Toru H, Pawankar R, Ra C, Yata J, Nakahata T (1998) Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. The Journal of allergy and clinical immunology 102:491-502.
    Toward TJ, Broadley KJ (2004) Early and late bronchoconstrictions, airway hyper-reactivity, leucocyte influx and lung histamine and nitric oxide after inhaled antigen: effects of dexamethasone and rolipram. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 34:91-102.
    Turato G, Baraldo S, Zuin R, Saetta M (2007) The laws of attraction: chemokines, neutrophils and eosinophils in severe exacerbations of asthma. Thorax 62:465-466.
    Undem BJ, Graziano FM, Buckner CK (1985) Studies on beta-adrenoceptors of purified mast cells from guinea-pig lung. European journal of pharmacology 109:413-416.
    Urata Y, Yoshida S, Irie Y, Tanigawa T, Amayasu H, Nakabayashi M, Akahori K (2002) Treatment of asthma patients with herbal medicine TJ-96: a randomized controlled trial. Respiratory medicine 96:469-474.
    Volgyesi GA, Tremblay LN, Webster P, Zamel N, Slutsky AS (2000) A new ventilator for monitoring lung mechanics in small animals. Journal of applied physiology 89:413-421.
    Watson N, Magnussen H, Rabe KF (1995) Pharmacological characterization of the muscarinic receptor subtype mediating contraction of human peripheral airways. The Journal of pharmacology and experimental therapeutics 274:1293-1297.
    Wilkinson JR, Roberts JA, Bradding P, Holgate ST, Howarth PH (1992) Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. Bmj 305:931-932.
    Williams TJ, Griffiths-Johnson DA, Jose PJ, Collins PD (1995) Eosinophil chemoattractants generated in vivo. Agents and actions Supplements 46:1-9.
    Wright AL, Sherrill D, Holberg CJ, Halonen M, Martinez FD (1999) Breast-feeding, maternal IgE, and total serum IgE in childhood. The Journal of allergy and clinical immunology 104:589-594.
    Wu W, Samoszuk MK, Comhair SA, Thomassen MJ, Farver CF, Dweik RA, Kavuru MS, Erzurum SC, Hazen SL (2000) Eosinophils generate brominating oxidants in allergen-induced asthma. The Journal of clinical investigation 105:1455-1463.
    Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, Kinet JP, Galli SJ (1997) IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. The Journal of experimental medicine 185:663-672.
    Yamaguchi M, Sayama K, Yano K, Lantz CS, Noben-Trauth N, Ra C, Costa JJ, Galli SJ (1999) IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. Journal of immunology 162:5455-5465.
    Zaagsma J, van der Heijden PJ, van der Schaar MW, Bank CM (1983) Comparison of functional beta-adrenoceptor heterogeneity in central and peripheral airway smooth muscle of guinea pig and man. Journal of receptor research 3:89-106.
    Zhang T, Srivastava K, Wen MC, Yang N, Cao J, Busse P, Birmingham N, Goldfarb J, Li XM (2010) Pharmacology and immunological actions of a herbal medicine ASHMI on allergic asthma. Phytotherapy research : PTR 24:1047-1055.

    無法下載圖示 校內:2019-02-07公開
    校外:不公開
    電子論文尚未授權公開,紙本請查館藏目錄
    QR CODE